AI Article Synopsis
- Acupuncture can effectively treat various nervous system diseases, including vascular dementia.
- A study with 168 patients showed that combining donepezil hydrochloride with acupuncture enhanced cognitive function compared to donepezil alone.
- Results indicated improved P300 event-related potential measurements and higher Mini-Mental State Examination scores, highlighting acupuncture's neuroprotective benefits.
Article Abstract
Acupuncture can be used to treat various nervous system diseases. Here, 168 vascular dementia patients were orally administered donepezil hydrochloride alone (5 mg/day, once a day for 56 days), or combined with acupuncture at Shenting (DU24), Tianzhu (BL10), Sishencong (Extra), Yintang (Extra), Renzhong (DU26), Neiguan (PC6), Shenmen (HT7), Fengchi (GB20), Wangu (GB12) and Baihui (DU20) (once a day for 56 days). Compared with donepezil hydrochloride alone, P300 event related potential latency was shorter with an increased amplitude in patients treated with donepezil hydrochloride and acupuncture. Mini-Mental State Examination score was also higher. Moreover, these differences in P300 latency were identified within different infarcted regions in patients treated with donepezil hydrochloride and acupuncture. These findings indicate that acupuncture combined with donepezil hydrochloride noticeably improves cognitive function in patients with vascular dementia, and exerts neuroprotective effects against vascular dementia.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829012 | PMC |
| http://dx.doi.org/10.4103/1673-5374.179059 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Biomarkers.
Alzheimers Dement
December 2024
Baehwa University, Seoul, Seoul, Korea, Republic of (South).
Background: It is difficult to predict of long-term treatment response of AD to medical treatment when starting medication. We explored EEG brain connectivity as a potential biomarker for long-term medication outcomes in patients with AD.
Methods: Resting-state EEG was recorded from a total of 56 AD patients (mean age = 73.
Developing Topics.
Alzheimers Dement
December 2024
Pontifical Catholic University, Londrina, Parana, Brazil.
Background: The association of Alzheimer's disease (AD) and sarcopenia diagnoses is quite common, but frequently sarcopenia is underdiagnosed in this population and it may be contributing to the worsening of functionality in the person with AD.
Method: Fifty-five adults over age 60 from a public outpatient clinic in Londrina - Parana- Brazil diagnosed with Alzheimer's disease were followed during the years 2022 and 2023. They were subjected to a sociodemographic questionnaire, BMI assessment, cognitive assessment using the MMSE, functionality assessment using the Katz Index and to a sarcopenia screening test SARC-F +CC.
Background: Cholinergic innervation is particularly vulnerable in many neurodegenerative diseases such as Alzheimer's diseases. Nerve growth factor (NGF) plays a major role in the maintenance and function of cholinergic neurons, and a decrease in trophic signalling by NGF-Tropomyosin receptor kinase A (TrkA) contributes to cholinergic and synaptic degeneration. E2511 is a novel small molecule TrkA biased positive allosteric modulator showing an increase in specific trophic signalling via direct binding to TrkA with a potential to recover and reinnervate damaged cholinergic neurons.
View Article and Find Full Text PDFBackground: Since lecanemab, an anti-amyloid monoclonal antibody targeting Aβ protofibrils, only modestly impacts cognition (27% slower cognitive decline over 18 months), tracking the effects on the brain in the early months is a clinical challenge. Serial noncontrast MRI scans are required by the FDA, to assess for the occurrence of amyloid-related imaging abnormalities (ARIA). Arterial spin-labeling MR (ASL-MR) is a 4-minute non-contrast easily-added sequence.
View Article and Find Full Text PDFBackground: Senile dementia (SD) is a deteriorative organic brain disorder and it comprises Alzheimer's disease (AD) as a major variant. SD is shown impairment of mental capacities whereas AD is degeneration of neurons. According to World Health Organization (WHO) report; more than 55 million peoples have dementia and it is raising 10 million new cases every year.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!